Caroline serves as the Scientific Officer for the IIN. In this role, she manages the scientific program and provides support to IIN affiliated students, postdoctoral fellows, and Ryan Fellows.
Caroline successfully launched her career in the field of nanotechnology as an IIN postdoctoral fellow in the laboratory of Prof. Chad A. Mirkin. During her postdoctoral research, she developed a first-in-kind siRNA-based nanotherapeutic to treat Glioblastoma Multiforme (the most common and most malignant cancer that begins within the brain). She has been actively managing the development program for this drug product, which is planned to go into clinical trials in 2016. Her passion is to help translate research ideas into viable products for societal benefit.
Caroline received her B.S. in chemistry from the University of Michigan – Ann Arbor, her M.S. in Psychology (Brain & Behavior) from the University of Toronto, and her Ph.D. in neurobiology & physiology from Northwestern.
Sign up for our newsletter to receive information on events, news, and articles.